Glycogen storage disease type I as fat. When digestion of a meal is complete, insulin levels fall, and enzyme systems in the liver cells begin to remove glucose molecules from strands of glycogen in the form of G6P. This process is termed glycogenolysis. The G6P remains within the liver cell unless the phosphate is cleaved by glucose-6-phosphatase. This dephosphorylation reaction produces free glucose and free anions. The free glucose molecules can be transported out of the liver cells into the blood to maintain an adequate supply of glucose to the brain and other organs of the body. Glycogenolysis can supply the glucose needs of an
Alpha cell Alpha cell Alpha cells (more commonly alpha-cells or α-cells) are endocrine cells in the pancreatic islets of the pancreas. They make up to 20% of the human islet cells synthesizing and secreting the peptide hormone glucagon, which elevates the glucose levels in the blood. To elevate glucose levels, glucagon binds to receptors on hepatocytes (liver cells) and some other cells (e.g. kidney cells). This activates an enzyme, glycogen phosphorylase, inside the hepatocyte to hydrolyse glycogen to glucose. This process is called glycogenolysis. In rodents, alpha cells are located in the periphery of the islets, however in humans the islet architecture